DUCA, LEONARDO
 Distribuzione geografica
Continente #
AS - Asia 800
NA - Nord America 744
EU - Europa 426
SA - Sud America 110
AF - Africa 10
Totale 2.090
Nazione #
US - Stati Uniti d'America 706
SG - Singapore 397
CN - Cina 149
IT - Italia 138
RU - Federazione Russa 107
BR - Brasile 87
VN - Vietnam 86
HK - Hong Kong 68
JP - Giappone 37
DE - Germania 36
GB - Regno Unito 30
FI - Finlandia 24
IN - India 24
CA - Canada 20
PL - Polonia 16
NL - Olanda 15
MX - Messico 13
AT - Austria 12
AR - Argentina 11
ES - Italia 10
BD - Bangladesh 9
TR - Turchia 7
IE - Irlanda 6
SE - Svezia 6
CZ - Repubblica Ceca 5
FR - Francia 5
LT - Lituania 5
EC - Ecuador 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
ID - Indonesia 3
IQ - Iraq 3
PY - Paraguay 3
BE - Belgio 2
CH - Svizzera 2
IL - Israele 2
JO - Giordania 2
RS - Serbia 2
TN - Tunisia 2
UA - Ucraina 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
CO - Colombia 1
CR - Costa Rica 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.090
Città #
Singapore 243
San Jose 117
Ashburn 66
Hong Kong 65
Beijing 62
Rome 58
Los Angeles 43
Tokyo 37
Ho Chi Minh City 32
Santa Clara 31
New York 29
Council Bluffs 23
Hanoi 20
Engelhard 19
Helsinki 19
Milan 17
Buffalo 16
Orem 15
Fairfield 13
Munich 13
The Dalles 13
Montreal 12
Moscow 12
Nuremberg 12
Dallas 11
Chandler 10
Warsaw 10
Frankfurt am Main 9
Mexico City 9
St. George 9
Wilmington 9
Chicago 7
Poplar 7
Redondo Beach 7
Amsterdam 6
Brooklyn 6
Suzhou 6
Chennai 5
Denver 5
London 5
Stockholm 5
São Paulo 5
Toronto 5
Vienna 5
Ann Arbor 4
Brno 4
Chandigarh 4
Houston 4
Lappeenranta 4
Manchester 4
Seattle 4
Belgrade 3
Caxias do Sul 3
City of London 3
Dublin 3
Gdynia 3
Haiphong 3
Hải Dương 3
Marano di Napoli 3
Mumbai 3
Naples 3
New Delhi 3
San Francisco 3
São Luís 3
Tampa 3
Thrissur 3
Amman 2
Ancona 2
Ankara 2
Baghdad 2
Bari 2
Belo Horizonte 2
Bengaluru 2
Biên Hòa 2
Boardman 2
Boston 2
Brasília 2
Brussels 2
Buenos Aires 2
Carapicuíba 2
Conselheiro Lafaiete 2
Detroit 2
Dhaka 2
Eagleville 2
Elk Grove Village 2
Genzano di Roma 2
Ha Long 2
Helena 2
Jakarta 2
Lauterbourg 2
Lomas de Zamora 2
Maceió 2
Medford 2
Menlo Park 2
Miami 2
Milazzo 2
Milwaukee 2
Mislata 2
Nepi 2
Newcastle upon Tyne 2
Totale 1.269
Nome #
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection 158
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 144
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 110
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 90
Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response 87
ULTRASENSITIVE HBV-RNA QUANTIFICATION AS A PROMISING BIOMARKER TO OPTIMIZE THE STAGING OF CHRONIC HBV INFECTION AND TO DETECT MINIMAL VIRAL ACTIVITY UNDER PROLONGED VIROLOGICAL SUPPRESSION AND OCCULT HBV INFECTION. 87
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 86
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens 86
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 84
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 84
Ultrasensitive HBV-RNA quantification by droplet digital PCR is a promising biomarker to optimize the staging of chronic HBV infection and to identify minimal viral activity under prolonged virological suppression. 78
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 76
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 74
Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa 72
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 70
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 70
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 68
KINETICS OF THE THREE HBSAG ISOFORMS ALONG WITH HDV-RNA PREDICT VIROLOGICAL RESPONSE IN CHD PATIENTS TREATED WITH BULEVIRTIDE UP TO 96 WEEKS P 215 65
Heterogeneity in the diagnostic sensitivities of HDV RNA quantification assays used in clinical practice in Italy: data from the first national quality control multicenter study. 65
Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks 63
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. 62
Heterogeneity in the diagnostic performances of HDV RNA quantification assays used in clinical practice in Italy: results from a national quality control multicenter study. 62
Total HIV DNA and cell-associated HIV RNA viral reservoirs in PBMCs and GALT in patients on triple-ART and switching to dual-ART regimens. 58
Different diagnostic performances of HDV RNA quantification assays used in clinical practicein Italy: results from a national quality control multicenter study. 55
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 55
HBs isoforms as innovative biomarkers in predicting virological response in chronic hepatitis delta patients treated with bulevirtide monotherapy. 48
Kinetics of the three HBsAg forms along with HDV-RNA predict virological and biochemical responses in chronic hepatitis delta patients treated with bulevirtide for 48 weeks. 47
HBs isoforms can play a role in predicting virological response in patients with chronic hepatitis delta under bulevirtide monotherapy. 42
The composition of HBsAg along with HDV-RNA predicts virological response in chronic hepatitis delta patients treated with bulevirtide for 48 weeks. 35
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. 16
Totale 2.197
Categoria #
all - tutte 8.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.083


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 2 0
2021/202222 1 0 0 3 0 3 4 0 7 1 0 3
2022/202330 2 2 7 1 3 4 2 5 4 0 0 0
2023/2024127 2 0 1 6 1 4 2 0 0 92 4 15
2024/2025538 25 110 80 29 26 56 58 14 42 24 42 32
2025/20261.444 200 74 129 182 167 60 179 186 154 94 19 0
Totale 2.197